Bench-to-bedside review: Clinical experience with the endotoxin activity assay
about
Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers.Systemic endotoxin activity correlates with clot formation: an observational study in patients with early systemic inflammation and sepsis.Polymyxin B hemoperfusion: a mechanistic perspective.Systemic cytokine and interferon responsiveness Patterns in HIV and HCV mono and co-infectionsEndotoxin Elimination in Patients with Septic Shock: An Observation Study.Efficacy of polymyxin B-immobilized fiber hemoperfusion for patients with septic shock caused by Gram-negative bacillus infection.A comparative study of blood endotoxin detection in haemodialysis patientsA Broad-Spectrum Infection Diagnostic that Detects Pathogen-Associated Molecular Patterns (PAMPs) in Whole BloodEndotoxemia in end-stage kidney disease.The role of immune and metabolic biomarkers for improved management of sepsis patients.Chasing a ghost?--Issues with the determination of circulating levels of endotoxin in human blood.Endotoxemia-menace, marker, or mistake?Prognostic value of endotoxin activity assay in patients with severe sepsis after cardiac surgery.The Role of Endotoxin in the Setting of Cardiorenal Syndrome Type 5.Novel Insights into the Direct Removal of Endotoxin by Polymyxin B Hemoperfusion.Usefulness of the endotoxin activity assay as a biomarker to assess the severity of endotoxemia in critically ill patients.Endotoxin Effects on Cardiac and Renal Functions and Cardiorenal Syndromes.The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients
P2860
Q33565654-06438477-2191-4D5E-929E-D51F3663D985Q33754830-18FC90E2-5CB9-4D81-9024-9DD7975BED6AQ34429986-4600817B-005C-4E2A-ADC2-193FB14A6C96Q34439925-71D0A4F0-8934-49B1-BE4B-0EECBD3F0336Q36249299-A3F8F7DF-DE7C-42FE-92C5-73D39D57D344Q36328053-27CA38A8-FE74-429D-A5F4-29E1E6D20E45Q37139884-73A5DFC7-0D71-4913-A39D-DC48EDA1A94BQ37149965-CE6DAD4A-0E4D-47EC-96C0-72503A384C20Q38231473-C70E8996-6DBD-4D59-A47C-1F762C32D396Q38234688-367C33AC-91E3-44CB-91A0-30149C856BA1Q38687215-25F52BCB-EB8A-471E-B606-C5E7149814C6Q38897447-DEB0FD55-E020-43A2-8B3A-145B2C6B2E53Q41035074-9394BC50-9A32-42B5-93F0-94AB4DCC6974Q50102449-E6C68CE1-B946-4FBE-AAD3-B5174567512EQ50591201-83236402-FEED-4F20-8640-70A83A35DEC1Q50736110-7412DAB4-6275-44B9-A993-0A353CAC8FEEQ52743944-1D2DBBA5-07F5-4CEB-89DB-D6EE9AC8D606Q58113483-8C8FB1D4-555C-4493-8453-7FF363D57FD7
P2860
Bench-to-bedside review: Clinical experience with the endotoxin activity assay
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Bench-to-bedside review: Clinical experience with the endotoxin activity assay
@en
type
label
Bench-to-bedside review: Clinical experience with the endotoxin activity assay
@en
prefLabel
Bench-to-bedside review: Clinical experience with the endotoxin activity assay
@en
P2093
P2860
P356
P1433
P1476
Bench-to-bedside review: Clinical experience with the endotoxin activity assay
@en
P2093
Alexander D Romaschin
David J Klein
John C Marshall
P2860
P2888
P356
10.1186/CC11495
P577
2012-12-03T00:00:00Z
P5875
P6179
1017963503